meet the training leader
Prof. Dr. Tudor Arvinte
Titular Professor of Biopharmaceutics, School of Pharmaceutical Sciences, University of Geneva, and CEO, Therapeomic, Inc.
Switzerland
All sessions of this unique course online
Live interaction options between the delegates and trainer
Available via mobile, tablet or laptop
Reveal the full schedule of the training as well as key topics, course objectives, key takeaways, special features, and the trainer bio!
Studies of aggregates formation after mixing biopharmaceuticals with human plasma and human blood: Implications for in vivo toxicity and immunogenicity
Examples of biopharmaceuticals will include: peptides, small proteins, antibodies, large proteins, biosimilars, different vaccines (based on proteins, nanoparticles, viruses)
Complexity and diversity of protein aggregates in biopharmaceuticals
Principles of different methods for analysis of aggregation and particulate matter
In use compatibility studies
Compatibility of biopharmaceuticals with primary packaging: characterization of leachables and extractables
Importance of formulation for the market success of biopharmaceuticals
Regulatory aspects regarding aggregates and particulates
